Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03961971
Title Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

gliosarcoma

glioblastoma

Therapies

Sabatolimab + Spartalizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.